Overactive Bladder
Association of healthy eating index-2015 and overactive bladder: a cross-sectional study.
October 6, 2024
Associations of overactive bladder (OAB) with suicidal ideation incidence and all-cause mortality among the U.S. population.
October 6, 2024
Differences in Advanced Therapeutic Modalities for Overactive Bladder in the United States by Race.
October 6, 2024
Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review.
October 6, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication
September 30, 2024
Trends of Overactive Bladder and Pharmacologic Treatment Among U.S. Women.
September 29, 2024
Botulinum Neurotoxin Type A in paediatric non-neurogenic therapy resistant overactive bladder: a cohort study.
September 29, 2024
A Multicenter Prospective Sham-Controlled Trial Evaluating a Physiologic Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder (REDUCEOAB).
September 22, 2024
Association Between Proton Pump Inhibitor Use and Overactive Bladder Risk in Adults: A Cross-Sectional Study.
September 22, 2024
Association analysis of ADRB3:rs4994 with urodynamic outcome, six months after a single intra-detrusor injection of botulinum toxin, in women with overactive bladder.
September 22, 2024
Association between weight-adjusted waist index and overactive bladder: a cross-sectional study based on 2009-2018 NHANES.
September 22, 2024
Overactive bladder: results from patients treated by hyaluronic acid-chondroitin sulphate therapy.
September 15, 2024
Causal effects of gut microbiota on risk of overactive bladder symptoms: a two-sample Mendelian randomization study.
September 15, 2024